olaparib,abiraterone
astrazeneca,merck
['crpc', 'pcsm', 'propel', 'prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
the #oncoalerttoptweet day 1 #gu23
tweet propel
a new doublet option in mcrpc #prostatecancer - parpi plus nht, by noel clarke. overall survival benefit of 7 mo very high in this setting. new standard of care? #pcsm best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨